0.24% 0.010

Oramed Pharmaceuticals Inc (ORMP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	100.00% -	1.594	1.988	-	-
Operating Income/Loss	24.41% -2.766	-3.659	-5.672	-2.427	-2.489
Nonoperating Income/Loss	131.32% 103.74	44.85	15.18	61.47	15.37
Income/Loss From Continuing Operations Before Tax	105.48% 101.59	49.44	9.797	59.45	13.13
Income Tax Expense/Benefit, Current	26.28% 1.634	1.294	-	-	-
Income Tax Expense/Benefit, Deferred	21.80	-	-	-	-
Income Tax Expense/Benefit	110.52% 23.43	11.13	-0.212	11.06	-0.126
Net Income/Loss	104.01% 78.16	38.31	10.01	48.39	13.26
Basic Average Shares	0.65% 41.04	40.77	-	41.76	41.74
Diluted Average Shares	1.27% 42.50	41.97	-	42.77	42.61
Basic Earnings Per Share	102.13% 1.90	0.94	-	1.16	0.32
Diluted Earnings Per Share	102.20% 1.84	0.91	-	1.13	0.31

CRMD

$7.85

3.09%

DBVT

$9.75

0.72%

CADL

$8.03

4.18%

GYRE

$5.85

0.17%

WVE

$3.18

5.07%

ATTO

$13.83

4.62%